BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22431186)

  • 1. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection.
    Varchetta S; Mele D; Mantovani S; Oliviero B; Cremonesi E; Ludovisi S; Michelone G; Alessiani M; Rosati R; Montorsi M; Mondelli MU
    Hepatology; 2012 Sep; 56(3):841-9. PubMed ID: 22431186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
    Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.
    Nattermann J; Feldmann G; Ahlenstiel G; Langhans B; Sauerbruch T; Spengler U
    Gut; 2006 Jun; 55(6):869-77. PubMed ID: 16322112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
    Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
    Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
    Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG
    Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
    Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
    Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
    Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
    J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56
    Mele D; Mantovani S; Oliviero B; Grossi G; Lombardi A; Mondelli MU; Varchetta S
    J Hepatol; 2017 Dec; 67(6):1148-1156. PubMed ID: 28803951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
    Golden-Mason L; Rosen HR
    Liver Transpl; 2006 Mar; 12(3):363-72. PubMed ID: 16498647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions.
    Holder KA; Stapleton SN; Gallant ME; Russell RS; Grant MD
    J Immunol; 2013 Sep; 191(6):3308-18. PubMed ID: 23960237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.
    Miyagi T; Takehara T; Nishio K; Shimizu S; Kohga K; Li W; Tatsumi T; Hiramatsu N; Kanto T; Hayashi N
    J Hepatol; 2010 Sep; 53(3):424-30. PubMed ID: 20554341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing.
    Morishima C; Paschal DM; Wang CC; Yoshihara CS; Wood BL; Yeo AE; Emerson SS; Shuhart MC; Gretch DR
    Hepatology; 2006 Mar; 43(3):573-80. PubMed ID: 16496327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
    Ciesek S; Liermann H; Hadem J; Greten T; Tillmann HL; Cornberg M; Aslan N; Manns MP; Wedemeyer H
    J Viral Hepat; 2008 Mar; 15(3):200-11. PubMed ID: 18233993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.
    Ahlenstiel G; Titerence RH; Koh C; Edlich B; Feld JJ; Rotman Y; Ghany MG; Hoofnagle JH; Liang TJ; Heller T; Rehermann B
    Gastroenterology; 2010 Jan; 138(1):325-35.e1-2. PubMed ID: 19747917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
    Tanimine N; Tanaka Y; Abe T; Piao J; Chayama K; Ohdan H
    Transplantation; 2016 Feb; 100(2):355-64. PubMed ID: 26714120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells lacking FcεRIγ are associated with reduced liver damage in chronic hepatitis C virus infection.
    Oh JS; Ali AK; Kim S; Corsi DJ; Cooper CL; Lee SH
    Eur J Immunol; 2016 Apr; 46(4):1020-9. PubMed ID: 26712042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequencies of CD158b+ NK cells are associated with persistent hepatitis C virus infections.
    Ji HF; Wang J; Yu L; Niu JQ; Ayana DA; Jiang YF
    Ann Hepatol; 2013; 12(4):539-47. PubMed ID: 23813131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
    J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hepatitis C in the advanced adult and elderly subjects.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.